MiR-668-3p in M2 macrophage-derived exosomes activates autophagy through the ETS1/EGFR axis and promotes cisplatin resistance in gastric cancer
Zunqi Hu, Dapeng Xu, Zhi Zheng, Xin Huang, Zhenxin Zhu, Xin Zhang, Ziran Wei, Hongbing Fu, Weijun Wang, Dejun Yang, Ronglin Yan · 2025
Read MiR-668-3p in M2 macrophage-derived exosomes activates autophagy through the ETS1/EGFR axis and promotes cisplatin resistance in gastric cancer by Zunqi Hu, Dapeng Xu, Zhi Zheng, Xin Huang, Zhenxin Zhu, Xin Zhang, Ziran Wei, Hongbing Fu, Weijun Wang, Dejun Yang, Ronglin Yan (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12849143.txt.
Description
Zunqi Hu and co-authors explain in 2025 one way stomach cancer learns to resist the drug cisplatin. Immune cells called M2 macrophages sit near tumors and shed tiny parcels. Those parcels carry a small RNA, miR-668-3p, which the team found raised in drug-resistant tumor tissue.
Cancer cells take in the parcels and the RNA with them. The RNA silences a gene called ETS1, which lowers a growth receptor, EGFR. That drop switches on autophagy, the cell's self-eating cleanup, which helps the cells survive the drug. The chain held in cell tests and in mouse tumors. Blocking the small RNA is the authors' proposed route to restore drug sensitivity.
Catalog record
| CREATOR | Zunqi Hu, Dapeng Xu, Zhi Zheng, Xin Huang, Zhenxin Zhu, Xin Zhang, Ziran Wei, Hongbing Fu, Weijun Wang, Dejun Yang, Ronglin Yan |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 77 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |